🇺🇸 FDA
Patent

US 12295941

Viral inhibitors, the synthesis thereof, and intermediates thereto

granted A61KA61K31/4184A61K31/7056

Quick answer

US patent 12295941 (Viral inhibitors, the synthesis thereof, and intermediates thereto) held by Takeda Pharmaceutical Company Limited expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/4184, A61K31/7056, A61K9/0053, A61P